Total Payments
$3,815
2024 Payments
$294.63
Companies
35
Transactions
186
Medicare Patients
964
Medicare Billing
$98,965
Payment Breakdown by Category
Food & Beverage$3,805 (99.7%)
Education$10.52 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,805 | 185 | 99.7% |
| Education | $10.52 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $825.94 | 33 | $0 (2024) |
| Lilly USA, LLC | $364.79 | 14 | $0 (2024) |
| AbbVie Inc. | $360.56 | 17 | $0 (2023) |
| PFIZER INC. | $344.36 | 14 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $331.92 | 23 | $0 (2021) |
| Merck Sharp & Dohme LLC | $317.57 | 25 | $0 (2023) |
| Koya Medical, Inc. | $167.29 | 1 | $0 (2024) |
| Medtronic, Inc. | $166.09 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $139.01 | 9 | $0 (2023) |
| Amgen Inc. | $89.77 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $294.63 | 7 | Koya Medical, Inc. ($167.29) |
| 2023 | $700.50 | 35 | Novo Nordisk Inc ($193.56) |
| 2022 | $744.13 | 21 | Novo Nordisk Inc ($360.33) |
| 2021 | $499.47 | 28 | AbbVie Inc. ($175.45) |
| 2020 | $250.25 | 17 | AstraZeneca Pharmaceuticals LP ($80.38) |
| 2019 | $380.88 | 26 | PFIZER INC. ($74.08) |
| 2018 | $444.91 | 22 | PFIZER INC. ($192.09) |
| 2017 | $500.26 | 30 | Lilly USA, LLC ($139.30) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Rhythm Pharmaceuticals, Inc. | IMCIVREE (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: Genetic Disease | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Obesity | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Obesity | ||||||
| 09/22/2024 | Koya Medical, Inc. | Dayspring (Device), Dayspring, Koya Medical | Food and Beverage | Cash or cash equivalent | $167.29 | General |
| Category: Lymphatic & Venous Issues | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Obesity | ||||||
| 11/30/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: UROLOGY | ||||||
| 11/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.41 | General |
| 10/05/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: VACCINES | ||||||
| 09/21/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Diabetes | ||||||
| 08/24/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: VACCINES | ||||||
| 08/17/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $34.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Diabetes | ||||||
| 08/03/2023 | Merck Sharp & Dohme LLC | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2023 | AbbVie Inc. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Obesity | ||||||
| 06/29/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 06/22/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Diabetes | ||||||
| 06/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Diabetes | ||||||
| 05/26/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $86.18 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 219 | 289 | $43,517 | $22,694 |
| 2022 | 5 | 219 | 282 | $47,475 | $26,074 |
| 2021 | 7 | 254 | 337 | $49,712 | $27,221 |
| 2020 | 8 | 272 | 352 | $49,367 | $22,977 |
Total Patients
964
Total Services
1,260
Medicare Billing
$98,965
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 128 | $22,357 | $10,558 | 47.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 70 | 70 | $15,050 | $8,965 | 59.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $2,970 | $1,484 | 50.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $1,886 | $1,000 | 53.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $585.00 | $449.10 | 76.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 21 | $567.00 | $199.92 | 35.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 17 | $102.00 | $37.40 | 36.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $21,285 | $12,961 | 60.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 123 | $21,279 | $10,638 | 50.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 33 | $4,026 | $1,963 | 48.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $507.00 | $376.74 | 74.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 12 | 14 | $378.00 | $134.31 | 35.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 144 | $24,462 | $12,814 | 52.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 78 | 78 | $16,560 | $10,431 | 63.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 44 | $5,108 | $2,344 | 45.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 15 | 15 | $1,320 | $978.90 | 74.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 17 | 25 | $675.00 | $242.75 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $507.00 | $218.40 | 43.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 17 | 18 | $1,080 | $191.52 | 17.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 75 | 137 | $22,879 | $9,540 | 41.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 70 | 70 | $14,646 | $8,173 | 55.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 66 | $7,392 | $2,954 | 40.0% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 21 | 21 | $1,617 | $1,274 | 78.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 21 | 21 | $819.00 | $346.80 | 42.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 11 | $748.00 | $293.90 | 39.3% |
About Dr. Bryan Cannon, MD
Dr. Bryan Cannon, MD is a Family Medicine healthcare provider based in Wildwood, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2009. The National Provider Identifier (NPI) number assigned to this provider is 1265662068.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Cannon, MD has received a total of $3,815 in payments from pharmaceutical and medical device companies, with $294.63 received in 2024. These payments were reported across 186 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($3,805).
As a Medicare-enrolled provider, Cannon has provided services to 964 Medicare beneficiaries, totaling 1,260 services with total Medicare billing of $98,965. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Wildwood, MO
- Active Since 07/15/2009
- Last Updated 02/08/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1265662068
Products in Payments
- Ozempic (Drug) $312.89
- FARXIGA (Drug) $221.68
- MOUNJARO (Drug) $196.59
- CHANTIX (Drug) $172.91
- Dayspring (Device) $167.29
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER (Device) $166.09
- QULIPTA (Drug) $157.76
- JANUVIA (Drug) $146.23
- Wegovy (Drug) $144.94
- TRULICITY (Drug) $137.17
- UBRELVY (Drug) $128.05
- BELSOMRA (Drug) $109.87
- JARDIANCE (Drug) $100.73
- Aimovig (Biological) $89.77
- SHINGRIX (Biological) $85.52
- Rybelsus (Drug) $78.15
- LYRICA (Drug) $65.36
- VRAYLAR (Drug) $58.26
- XARELTO (Drug) $52.43
- VYVANSE (Drug) $52.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wildwood
Lisa Burns, Md, MD
Family Medicine — Payments: $2,372
Family Medicine $2,372
Dr. Jerrold Ecklind, D.o, D.O
Family Medicine — Payments: $2,095
Family Medicine $2,095
Dr. Lindsay Ogle, Md, MD
Family Medicine — Payments: $978.36
Family Medicine $978.36
Dr. Mariel Gonzalez-Mendoza, Md, MD
Family Medicine — Payments: $183.94
Family Medicine $183.94
Dr. Brenda Izen, M.d, M.D
Family Medicine
Family Medicine